Stereotactic radiosurgery for AMD: A monte carlo-based assessment of patient-specific tissue doses

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 5, 2011, Pages 2334-2342

  Hanlon, Justin ^a   Firpo, Michael ^b   Chell, Erik ^b   Moshfeghi, Darius M ^c   Bolch, Wesley E ^a,d  

^a UNIVERSITY OF FLORIDA   (United States)

^b Oraya Therapeutics Inc   (United States)

^c STANFORD UNIVERSITY   (United States)

^d University of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MONTE CARLO METHOD; OPTIC NERVE DISEASE; ORBIT; PRIORITY JOURNAL; RADIATION CATARACT; RADIATION DOSE; RETINA MACULA AGE RELATED DEGENERATION; STATISTICAL MODEL; STEREOTACTIC RADIOSURGERY; TISSUE SPECIFICITY; X IRRADIATION;

ADOLESCENT; BRAIN; COMPUTER SIMULATION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LENS, CRYSTALLINE; MACULA LUTEA; MALE; MONTE CARLO METHOD; OPTIC NERVE; ORBIT; RADIATION DOSAGE; RADIATION INJURIES; RADIOSURGERY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; WET MACULAR DEGENERATION; YOUNG ADULT;

EID: 79956038099     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6421     Document Type: Article

References (40)

1. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477-485.
2. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355: 1419-1431.
3. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432-1444.
4. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2005;36:331-335.
5. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol. 2007;143:566-583.
6. Kaiser PK, Group DS. Efficiacy and safety of veteporfin PDT in combination with ranibizumab compared to ranibizumab monotherapy in AMD: 12-month outline of the DENALI study. Presented at: World Ophthalmology Congress; June 3-6, 2010; Berlin, Germany.
7. Sivagnanavel V, Evans JR, Ockrim Z, Chong V. Radiotherapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2004;CD004004.
8. Finger PT, Gelman YP, Berson AM, Szechter A. Palladium-103 plaque radiation therapy for macular degeneration: results of a 7 year study. Br J Ophthalmol. 2003;87:1497-1503.
9. Chakravarthy U, MacKenzie G. External beam radiotherapy in exudative age-related macular degeneration: a pooled analysis of phase I data. Br J Radiol. 2000;73:305-313.
10. Gertner M, Chell E, Pan KH, Hansen S, Kaiser PK, Moshfeghi DM. Stereotactic targeting and dose verification for age-related macular degeneration. Med Phys. 2010;37:600-606.
11. Hanlon J, Lee C, Chell E, et al. Kilovoltage stereotactic radiosurgery for age-related macular degeneration: assessment of optic nerve dose and patient effective dose. Med Phys. 2009;36:3671-3681.
12. Avila MP, Farah ME, Santos A, et al. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD. Retina. 2009;29:157-169.
13. Lee C, Chell E, Gertner M, et al. Dosimetry characterization of a multibeam radiotherapy treatment for age-related macular degeneration. Med Phys. 2008;35:5151-5160.
14. Avila MP, Farah ME, Santos A, Duprat JP, Woodward BW, Nau J. Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration. Br J Ophthalmol. 2009;93:305-309.
15. Jaakkola A, Heikkonen J, Tommila P, Laatikainen L, Immonen I. Strontium plaque brachytherapy for exudative age-related macular degeneration: three-year results of a randomized study. Ophthalmology. 2005;112:567-573.
16. Moshfeghi DM, Kaiser PK, Gertner M. Stereotactic low-voltage x-ray irradiation for age-related macular degeneration. Br J Ophthalmol. 2011;95:185-188.
17. Singh RP, Moshfeghi AA, Shusterman EM, McDormick SA, Gertner M. Evaluation of transconjunctival collimated external beam radiation for age-related macular degeneration (abstract). Presented at: American Academy of Ophthalmology Annual Meeting; November 8-11, 2008; Atlanta, GA.
18. Pelowitz DB. MCNPX User's Manual. Version 2.5.0. Los Alamos, NM: Los Alamos National Laboratory; 2005.
19. Lee C, Lodwick D, Williams JL, Bolch WE. Hybrid computational phantoms of the 15-year male and female adolescent: applications to CT organ dosimetry for patients of variable morphometry. Med Phys. 2008;35:2366-2382.
20. Chakravarthy U, Houston RF, Archer DB. Treatment of age-related subfoveal neovascular membranes by teletherapy: a pilot study. Br J Ophthalmol. 1993;77:265-273.
21. Evans JR, Sivagnanavel V, Chong V. Radiotherapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2010;5:CD004004.
22. Finger PT, Berson A, Sherr D, Riley R, Balkin RA, Bosworth JL. Radiation therapy for subretinal neovascularization. Ophthalmology. 1996;103:878-889.
23. Flaxel CJ, Friedrichsen EJ, Smith JO, Oeinck SC, Blacharski PA, Garcia CA, Chu HH. Proton beam irradiation of subfoveal choroidal neovascularisation in age-related macular degeneration. Eye (Lond). 2000;14(pt 2):155-164.
24. Jaakkola A, Heikkonen J, Tarkkanen A, Immonen I. Visual function after strontium-90 plaque irradiation in patients with age-related subfoveal choroidal neovascularization. Acta Ophthalmol Scand. 1999;77:57-61.
25. Jaakkola A, Heikkonen J, Tommila P, Laatikainen L, Immonen I. Strontium plaque irradiation of subfoveal neovascular membranes in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 1998;236:24-30.
26. Jaakkola A, Tommila P, Laatikainen L, Immonen I. Grading choroidal neovascular membrane regression after strontium plaque radiotherapy; masked subjective evaluation vs planimetry. Eur J Ophthalmol. 2001;11:269-276.
27. Zambarakji HJ, Lane AM, Ezra E, et al. Proton beam irradiation for neovascular age-related macular degeneration. Ophthalmology. 2006;113:2012-2019.
28. Amoaku WM, Archer DB. Fluorescein angiographic features, natural course and treatment of radiation retinopathy. Eye (Lond). 1990;4(pt 5):657-667.
29. Archer DB, Amoaku WM, Gardiner TA. Radiation retinopathy-clinical, histopathological, ultrastructural and experimental correlations. Eye (Lond). 1991;5(pt 2):239-251.
30. Archer DB, Gardiner TA. Ionizing radiation and the retina. Curr Opin Ophthalmol. 1994;5:59-65.
31. Finger PT, Berson A, Ng T, Szechter A. Ophthalmic plaque radiotherapy for age-related macular degeneration associated with subretinal neovascularization. Am J Ophthalmol. 1999;127:170-177.
32. Finger PT, Kurli M. Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy. Br J Ophthalmol. 2005;89:730-738.
33. Adams JA, Paiva KL, Munzenrider JE, Miller JW, Gragoudas ES. Proton beam therapy for age-related macular degeneration: development of a standard plan. Med Dosim. 1999;24:233-238.
34. Girkin CA, Comey CH, Lunsford LD, Goodman ML, Kline LB. Radiation optic neuropathy after stereotactic radiosurgery. Ophthalmology. 1997;104:1634-1643.
35. Stafford SL, Pollock BE, Leavitt JA, et al. A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2003;55:1177-1181.
36. Hasegawa T, Kobayashi T, Kida Y. Tolerance of the optic apparatus in single-fraction irradiation using stereotactic radiosurgery: evaluation in 100 patients with craniopharyngioma. Neurosurgery. 2010;66:688-694, discussion 694-685.
37. Chumak VV, Worgul BV, Kundiyev YI, et al. Dosimetry for a study of low-dose radiation cataracts among Chernobyl clean-up workers. Radiat Res. 2007;167:606-614.
38. Lawrence YR, Li XA, el Naqa I, et al. Radiation dose-volume effects in the brain. Int J Radiat Onc Biol Phy. 2010;76:S20-S27.
39. ICRP. Publication 70: Basic anatomical and physiological data for use in radiological protection: the skeleton. Ann ICRP. 1995;25: 1-180.
40. Hough M, Johnson PB, Rajon D, Jokisch D, Lee C, Bolch WE. An image-based skeletal dosimetry model for the ICRP reference adult male-internal electron sources. Phys Med Biol. In Press.